Results 291 to 300 of about 42,703 (308)

Screening for New Antirheumatic Drugs

Rheumatology, 1986
openaire   +3 more sources

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates

Ca-A Cancer Journal for Clinicians, 2006
David M Goldenberg
exaly  

Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature

Ca-A Cancer Journal for Clinicians, 2017
Paul J Hoskins, Walter H Gotlieb
exaly  

Functional Imaging of Cancer with Emphasis on Molecular Techniques

Ca-A Cancer Journal for Clinicians, 2007
Mohamed Houseni
exaly  

Screening for New Antirheumatic Drugs

Rheumatology, 1985
openaire   +3 more sources

Multiple Myeloma: Charging Toward a Bright Future

Ca-A Cancer Journal for Clinicians, 2007
Parameswaran N Hari
exaly  

Clinical development of novel therapeutics for castration‐resistant prostate cancer

Ca-A Cancer Journal for Clinicians, 2012
Matthew D Galsky, Alexander C Small, William K Oh   +2 more
exaly  

Rheumatic syndromes caused by antirheumatic drugs

Baillière's Clinical Rheumatology, 1991
Béla Szebenyi, P.J. Rooney, Géza P. Bálint, Petros Petrou   +3 more
openaire   +3 more sources

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

Chemical Reviews, 2016
Timothy C Johnstone, Kogularamanan Suntharalingam, Stephen J Lippard   +2 more
exaly